» Articles » PMID: 36580097

Prevalence of Osteoporosis in Older Male Veterans Receiving Hip-containing Computed Tomography Scans: Opportunistic Use of Biomechanical Computed Tomography Analysis (BCT)

Overview
Journal Osteoporos Int
Date 2022 Dec 29
PMID 36580097
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Osteoporosis care in men is suboptimal due to low rates of DXA testing and treatment. Biomechanical computed tomography analysis (BCT) can be applied "opportunistically" to prior hip-containing CT scans to measure femoral bone strength and hip BMD.

Methods: In this retrospective, cross-sectional study, we used BCT in male veterans with existing CT scans to investigate the prevalence of osteoporosis, defined by hip BMD (T-score ≤  - 2.5) or fragile bone strength (≤ 3500 N). 577 men, age ≥ 65 with abdominal/pelvic CTs performed in 2017-2019, were randomly selected for BCT analysis. Clinical data were collected via electronic health records and used with the femoral neck BMD T-score from BCT to estimate 10-year hip fracture risks by FRAX.

Results: Prevalence of osteoporosis by BCT increased with age (13.5% age 65-74; 18.2% age 75-84; 34.3% age ≥ 85), with an estimated overall prevalence of 18.3% for men age ≥ 65. In those with osteoporosis (n = 108/577), only 38.0% (41/108) had a prior DXA and 18.6% (7/108) had received osteoporosis pharmacotherapy. Elevated hip fracture risk by FRAX (≥ 3%) did not fully capture those with fragile bone strength. In a multivariate logistic regression model adjusted for age, BMI, race, and CT location, end stage renal disease (odds ratio 7.4; 95% confidence interval 2.3-23.9), COPD (2.2; 1.2-4.0), and high-dose inhaled corticosteroid use (3.7; 1.2-11.8) were associated with increased odds of having osteoporosis by BCT.

Conclusion: Opportunistic BCT in male veterans provides an additional avenue to identify patients who are at high risk of fractures.

Citing Articles

Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes.

Ruggiero C, Caffarelli C, Calsolaro V, Tafaro L, Riuzzi F, Bubba V Drugs Aging. 2025; 42(1):21-38.

PMID: 39775765 DOI: 10.1007/s40266-024-01163-4.


Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer.

Lin J, Hearn C, Getzen E, Long Q, Lee D, Keaveny T Eur Urol Oncol. 2023; 7(4):794-803.

PMID: 37926618 PMC: 11268319. DOI: 10.1016/j.euo.2023.10.016.

References
1.
Shuhart C, Yeap S, Anderson P, Jankowski L, Lewiecki E, Morse L . Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom. 2019; 22(4):453-471. DOI: 10.1016/j.jocd.2019.07.001. View

2.
Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

3.
Narla R, Hirano L, Lo S, Anawalt B, Phelan E, Matsumoto A . Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures. J Investig Med. 2019; 67(4):743-749. DOI: 10.1136/jim-2018-000907. View

4.
Trombetti A, Stoermann C, Chevalley T, van Rietbergen B, Herrmann F, Martin P . Alterations of bone microstructure and strength in end-stage renal failure. Osteoporos Int. 2012; 24(5):1721-32. DOI: 10.1007/s00198-012-2133-4. View

5.
Balasubramanian A, Tosi L, Lane J, Dirschl D, Ho P, OMalley C . Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009. J Bone Joint Surg Am. 2014; 96(7):e52. DOI: 10.2106/JBJS.L.01781. View